InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (20 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
20
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Lloyd George W., Chief Executive Officer. Officer active across 1 company, notably Royalty Pharma plc. In total, 25 reports have been published. Split: 0 buy · 20 sells. Total volume traded: €30.6m. Activity tracked since 7 May 2021. The latest transaction was filed on 17 December 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Lloyd George W.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
79,346 shares@ US$38.56888.5% of flowClass A Ordinary SharesSEC:0001814899-25-000010:0
110,000 shares@ US$39.772813.4% of flowClass A Ordinary SharesSEC:0001814899-25-000008:0
47,798 shares@ US$38.27886.5% of flowClass A Ordinary SharesSEC:0001814899-25-000006:0
6,168 shares0Class A Ordinary SharesSEC:0001814899-25-000003:0
3,696 shares0Class A Ordinary SharesSEC:0001802768-25-000103:0
48,646 shares0Class A Ordinary SharesSEC:0001802768-25-000037:0
50,000 shares0Class A Ordinary SharesSEC:0001802768-23-000032:0
92,221 shares@ US$33.645310.4% of flowClass A Ordinary SharesSEC:0001209191-23-034792:0
100,000 shares@ US$37.061312.3% of flowClass A Ordinary SharesSEC:0001209191-23-021648:0
25,000 shares@ US$37.26633.2% of flowClass A Ordinary SharesSEC:0001209191-23-013398:0
20,531 shares@ US$43.10953.1% of flowClass A Ordinary SharesSEC:0001209191-22-058450:0
25,000 shares@ US$43.8534.0% of flowClass A Ordinary SharesSEC:0001209191-22-056677:0
11,859 shares@ US$43.91611.8% of flowClass A Ordinary SharesSEC:0001209191-22-045451:0
4,046 shares@ US$43.96760.6% of flowClass A Ordinary SharesSEC:0001209191-22-043689:0
19,557 shares@ US$42.90363.0% of flowClass A Ordinary SharesSEC:0001209191-22-043286:0
86,026 shares@ US$40.21270.011% mcap18.9% of flowClass A Ordinary SharesSEC:0001209191-22-032900:0
100,000 shares@ US$40.26770.012% mcap22.1% of flowClass A Ordinary SharesSEC:0001209191-22-031924:0
72,659 shares@ US$42.32628.8% of flowClass A Ordinary SharesSEC:0001209191-21-065639:0
4,913 shares@ US$39.81090.5% of flowClass A Ordinary SharesSEC:0001209191-21-048317:0
100 shares@ US$42.040.0% of flowClass A Ordinary SharesSEC:0000899243-21-028335:0
6,227 shares@ US$42.41510.7% of flowClass A Ordinary SharesSEC:0000950103-21-010244:0
20,000 shares@ US$46.45532.5% of flowClass A Ordinary SharesSEC:0000950103-21-008761:0
20,000 shares@ US$44.68532.4% of flowClass A Ordinary SharesSEC:0000950103-21-008571:0
12,500 shares@ US$42.09021.4% of flowClass A Ordinary SharesSEC:0000950103-21-008456:0
675,860 shares0Class A Ordinary SharesSEC:0000950103-21-007076:0
25 of 25 declarations
About Lloyd George W.
Lloyd George W. is Directeur Général at Royalty Pharma plc, where he is also EVP, Investments & CLO. Across 25 filings in total, the 25 sampled filings between 2021-05-11 and 2025-12-19 show only sales, for a total amount of EUR 30605915.
